等待开盘 07-06 09:30:00 美东时间
-0.160
-0.35%
今日重点评级关注:摩根士丹利:维持杜邦"标配"评级,目标价从52美元升至156美元;蒙特利尔银行:维持Taysha Gene Therapies"跑赢大市"评级,目标价从10美元升至14美元
06-24 14:08
Further to the announcement made on 20 May 2026, Smurfit Westrock (NYSE:SW) today announces that: (i) the secondary listing of its ordinary shares on the equity shares (international commercial companies secondary listing) category of the Official List of the UK Financial Conduct Authority; and (ii)...
06-22 18:38
看涨情绪爆棚!期权TOP10集体放量,微软多头全面逼空,狂赌月内再涨10%;Palantir暴涨近10%,一Call单最高狂飙16倍;赛富时获资金押注40%的上涨空间>>
06-01 19:45
今日重点评级关注:康托·菲茨杰拉德:维持Ultragenyx药业"超配"评级,目标价从84美元升至96美元;Ascendiant Capital:维持Liqtech国际"买入"评级,目标价从4.3美元升至4.4美元
05-22 10:18
Barclays analyst Pallav Mittal maintains Smurfit WestRock (NYSE:SW) with a Overweight and lowers the price target from $54 to $52.
05-21 23:11
Once the LSE Delisting takes effect, the Company will be solely listed on the New York Stock Exchange.Background to and Reasons for the LSE DelistingOn 30 April 2026, Smurfit Westrock announced its intention to undertake
05-20 18:32
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
Citigroup analyst Anthony Pettinari maintains Smurfit WestRock (NYSE:SW) with a Buy and lowers the price target from $53 to $51.
05-05 01:34
今日重点评级关注:Benchmark:维持史密斯微软件"买入"评级,目标价从2美元升至2.5美元;Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元
05-04 16:04
华盛资讯5月1日讯,Smurfit Westrock PLC公布2026财年Q1业绩,公司Q1营收77.12亿美元,同比增长0.7%,归母净利润0.65亿美元,同比下滑83.1%。
05-01 22:49